INTRODUCTION
============

Preterm birth (PTB) is an obstetric complication of complex etiology associated with significant neonatal mortality and morbidity worldwide. Numerous morbidities among infants born preterm have been reported to lead to both neonatal mortality and late sequelae such as respiratory distress syndrome, retinopathy of prematurity, neurological and neuro-developmental abnormalities, and lifelong vision and hearing impairment \[[@b1-jpmph-49-3-165]\]. Globally, more than 20 million infants are born every year with a birth weight less than 2500 g, with Asia and Africa witnessing the largest numbers. India alone accounts for 40% of the cases of low birth weight (LBW) in the developing world, and more than half of those in Asia \[[@b2-jpmph-49-3-165]\]. Various maternal demographic, behavioral, and clinical characteristics have been associated with PTB including maternal race/ethnicity, maternal age at either extreme, cigarette smoking, low pre-pregnancy weight, psychosocial stress, previous PTB, and maternal intrauterine infections \[[@b3-jpmph-49-3-165]\]. An association of bacterial vaginosis (BV) and periodontitis with adverse pregnancy outcomes has been reported among women belonging to various ethnic groups and geographical locations \[[@b4-jpmph-49-3-165]-[@b7-jpmph-49-3-165]\]. Despite substantial evidence suggesting the positive association of these infections with adverse pregnancy outcomes from elsewhere, routine screening of pregnant women for genital and periodontal infections is not a common practice in developing countries such as India. Considering the overall paucity of information regarding the risk factors for adverse pregnancy outcomes among Indian women, we undertook the present study to assess the magnitude of maternal infectious and non-infectious parameters and their association with PTB and LBW among a cohort of pregnant women.

METHODS
=======

Study Site, Design, and Population
----------------------------------

A prospective cohort study was carried out at a secondary care hospital in South India for a period of three years (May 2011 to April 2014). The study was approved by the institutional ethics committee of Kasturba Hospital, Manipal (no. IEC160/2010). Pregnant women aged 18 to 35 years and with a gestational age of 8 to 24 weeks visiting the Obstetrics Clinic for a routine antenatal check-up were invited to participate in the study. Pregnant women with medical diseases such as diabetes mellitus, hypertension, hypo/hyperthyroidism; obstetrical complications such as placenta previa, cervical cerclage, uterine fibroids, twin pregnancy; lifestyle habits such as smoking and consumption of alcohol; or infections such as HIV and syphilis were not included in the study. The sample size was calculated anticipating a prevalence of lower genital infections and periodontitis among 30% of the study population, a 10% prevalence of PTB and a relative precision of 25%. It was estimated that a sample of 756 women was needed to show a statistically significant association of maternal genitourinary tract and periodontal infections with PTB and LBW among the target study population.

After written informed consent for study enrollment had been obtained, structured interviews were carried out to gather data regarding socioeconomic, demographic, relevant medical, and obstetric history. Gestational age was estimated based on the date of the last menstrual period, followed by a confirmation using ultrasonography. The body mass index (BMI) of the study participants was calculated based on their weight (kg) and height (m) recorded during the study recruitment. Based on their BMI, women were classified as underweight (BMI ≤19.9 kg/m^2^), normal weight (20.0-24.9 kg/m^2^), overweight (25.0-29.9 kg/m^2^), and obese (≥30.0 kg/m^2^).

Testing for Genitourinary and Periodontal Infections
----------------------------------------------------

A clean catch mid-stream urine specimen was collected from each study participant during recruitment. Urine specimens were subjected to semi-quantitative microbiological culture using cysteine lactose electrolyte-deficient media. Bacterial isolates with significant counts (\>105 CFU/mL) were identified up to the species level and antimicrobial susceptibility testing for the isolates was tested and reported as per the Clinical and Laboratory Standards Institute guidelines. Women diagnosed with urinary tract infections (UTI) and/or asymptomatic bacteriuria (AB) were treated with a pathogen-specific antimicrobial agent. All the study participants underwent per speculum examination, during which high vaginal and endocervical swabs were collected for the microbiological diagnosis of lower genital tract infections such as BV, vulvovaginal candidiasis (VVC), trichomoniasis, and genital chlamydiasis. Diagnosis of BV was made by examination of Gram-stained high vaginal smears using Nugent's scoring system (NSS) \[[@b8-jpmph-49-3-165]\]. Other forms of vaginitis were diagnosed using a wet mount examination of the vaginal secretions for trichomoniasis and Gram-stained smear examination of the high vaginal swabs for VVC. Decisions regarding the treatment for vaginal infections and the choice of an antimicrobial agent for treatment was made by the obstetrician based on the clinical examination alone in the present study. DNA from the endocervical swab was extracted using a QIAamp DNA mini kit (Qiagen GmbH, Hilden, Germany) as per the manufacturer's instructions. The extracted DNA was used for detection of *Chlamydia trachomatis*. The oligonucleotide primers and the polymerase chain reaction mixture and conditions used in our study targeted the detection of a 201-bp region of the cryptic plasmid of *C. trachomatis* as described previously \[[@b9-jpmph-49-3-165]\]. A detailed periodontal examination was performed using the Community Periodontal Index (CPI) scoring system at the time of recruitment. A pathological pocket depth of at least 4 mm (CPI score ≥3) among any one of the six index teeth examined was diagnostic for periodontitis \[[@b10-jpmph-49-3-165]\]. Women diagnosed with periodontitis were not provided any form of treatment (antibiotics or scaling) in the present study.

Follow-up of Study Participants and Pregnancy Outcomes
------------------------------------------------------

Study participants were followed for the rest of their gestational period, and the occurrence of any adverse event(s) such as late pregnancy loss between 20 weeks and 24 weeks of gestation, gestational diabetes, gestational hypertension, intrauterine growth restriction, threatened preterm labor, UTI, symptomatic genital infections during later stages of pregnancy, and oligohydroamnios were recorded. PTB was considered to be any birth occurring before the completion of 37 weeks of gestation. LBW was considered to be a birth weight of less than 2500 g. Infants born preterm with LBW were considered to be preterm low birth weight (PLBW). For the final analysis to assess the risk factors for PTB, PLBW, and LBW among the study population, data regarding the infectious and non-infectious parameters of 710 women was included.

Statistical Analysis
--------------------

Subject information was digitized and analyzed using the SPSS version 16.0 (SPSS South Asia Pvt. Ltd., Bangalore, India). The proportion of cases with maternal genitourinary and periodontal infections were estimated using descriptive statistics. The incidence density per 1000 person-weeks of gestation for PTB and LBW were estimated among the present study cohort. The chi-square test was used for the comparison of baseline and infectious parameters among the members of the study population with follow-up data available and those that were lost during follow-up. The association of infectious and non-infectious maternal parameters with adverse pregnancy outcomes was estimated in terms of crude relative risk (CRR) with a 95% confidence interval (CI) using univariate Cox regression. Using forward Wald multivariate Cox regression, risk factors for PTB, PLBW, and LBW were assessed separately after adjusting for the maternal baseline, physical, and infectious covariates. Ultimately, independent risk factors with adjusted relative risk (ARR) and 95 % CI were reported.

RESULTS
=======

A total of 790 women were recruited for the study. The mean age of the study population was 27.18±3.54 years. The mean gestational age of the study population at inclusion was 14±4.2 weeks. The majority of the study subjects completed at least 12 years of schooling (n=518, 65%) and 69% (n=550) of them had a monthly household income of \>10 000 Indian rupees (INR). The mean height of the study population was 1.55±0.05 m (range, 1.35 to 1.72 m). The majority (n=506, 64%) of the study participants had a normal BMI. Slightly more than half (n=461, 58%) of the study participants were primi gravida. Among the 329 women who had had a previous pregnancy, 110 (33.4%) reported a history of abortion. Prior history of preterm delivery was reported among 10/219 (4.5%) of the women. A detailed description of the baseline characteristics among the study population is presented in [Table 1](#t1-jpmph-49-3-165){ref-type="table"}.

Using NSS, BV (Nugent's score, 7 to 10) was diagnosed among 48 (6%) of the women. Further, 108 (13.6%) women were found to have intermediate vaginal flora (Nugent's score, 4 to 6). VVC and trichomoniasis were observed among 97 (12.2%) and 94 (11.8%) women, respectively. None of the women tested were positive for *C. trachomatis*. Significant bacteriuria was observed in 57 (7.2%) women. Of these 57 women, AB was observed among 20 (35%) and the other 37 (65%) women had clinical symptoms of UTI. Among women with significant bacteriuria, *Escherichia coli* was the leading pathogen, in 42 (75%) of the cases, followed by *Klebsiella pneumoniae* in nine (16%). From the other five women, *Enterococcus* spp. was isolated in four (7%) and Proteus mirabilis in one (2%). Nitrofurantoin (52%) and cefixime (45%) were the most commonly prescribed antibiotics for treatment of significant bacteriuria. Overall, the proportion of women with AB in the present study population was 2.5% at the time of testing. Periodontitis was diagnosed in 90 (11.3%) women using CPI scoring. The proportion of maternal genitourinary and periodontal infections among the study population is detailed in [Table 1](#t1-jpmph-49-3-165){ref-type="table"}.

Pregnancy outcomes for 64 (8%) women were not available for the final analysis, as these women were lost to follow-up during the study. A detailed description of the study participants that were lost during follow-up is provided in [Table 1](#t1-jpmph-49-3-165){ref-type="table"}. Among the 726 women with follow-up data available, adverse events such as late pregnancy loss (n=16, 2.2%), gestational diabetes mellitus (n=38, 5.2%), gestational hypertension (n=22, 3%), UTI (n=23, 3.1%), symptomatic genital infections during the later stages of pregnancy (n=65, 8.9%), and oligohydramnios (n=31, 4.2%) were observed. Among the 710 women with a successful pregnancy, 54 (7.6%) women experienced preterm delivery. The mean gestational age of the women that delivered at term and preterm in the present study were 38.5±0.8 and 35.6±2.3 weeks, respectively. LBW was observed among 81 (11.4%) babies born in the study. The mean birth weight of the babies born was 2971±438.75 g. Among the 81 infants born with LBW, 34 (42%) of them were born preterm, and intrauterine growth restriction was observed in 11 (13.5%). Overall, the incidence densities of PTB and LBW among the study population were 3.2 (95% CI, 2.8 to 3.5) and 4.9 (95% CI, 4.6 to 5.2) per 1000 person-weeks of gestation, respectively.

Further, presence of more than one of the three infections, namely, periodontitis, BV, and intermediate vaginal flora, was observed in 34/710 (4.7%) women. Preterm delivery and LBW were observed among 23.5% (n=8) and 35.2% (n=12), respectively, of the 34 women with more than one infection (p \< 0.001), as compared to 10.4% (n=15) and 15.2% (n=22) of the 144 women with only one of the three infections. Using univariate Cox regression, we observed a significant association of maternal height less than 1.50 m, history of previous preterm delivery, gestational hypertension, oligohydramnios, BV, and periodontitis with PTB and/or LBW. Other maternal baseline characteristics such as BMI, level of education, monthly household income, and parity index did not have an association with adverse pregnancy outcomes. A detailed description of the association of maternal physical, demographic, and infectious parameters with PTB, PLBW, and LBW among the study population is provided in [Table 2](#t2-jpmph-49-3-165){ref-type="table"}.

Independent risk factors for PTB in the present study population were previous preterm delivery (ARR, 5.37; 95% CI, 1.5 to 19.1), periodontitis (ARR, 2.39; 95% CI, 1.1 to 4.9), Oligohydramnios (ARR, 5.23; 95% CI, 2.4 to 11.5), presence of Nugent's intermediate vaginal flora (ARR, 2.75; 95% CI, 1.4 to 5.1), gestational diabetes mellitus (ARR, 2.91; 95% CI, 1.0 to 8.3), and maternal height \<1.50 m (ARR, 2.21; 95% CI, 1.1 to 4.1). Similarly, independent risk factors for LBW were periodontitis (ARR, 3.38; 95% CI, 1.6 to 6.9), gestational hypertension (ARR, 3.70; 95% CI, 1.3 to 10.8), maternal height \<1.50 m (ARR, 2.66; 95% CI, 1.3 to 5.1), and genital infections during the later stages of pregnancy (ARR, 2.79; 95% CI, 1.2 to 6.1). Independent risk factors for PTB, PLBW, and LBW in the study population are presented in [Table 3](#t3-jpmph-49-3-165){ref-type="table"}.

DISCUSSION
==========

PTB is a prevalent obstetric complication associated with significant neonatal mortality and morbidity worldwide. Addressing the burden of PTB in developing countries is of public health importance due to its high (9 to 16%) prevalence. Though the exact etiopathogenesis of PTB is still unclear, in developing nations, prediction and/or diagnosis of this multifactorial process is made mainly based on the evidence reported in the western literature on the risk factors and probable pathological mechanisms \[[@b3-jpmph-49-3-165],[@b11-jpmph-49-3-165],[@b12-jpmph-49-3-165]\]. More recently, reports suggesting the disparity in risk factors for PTB due to ethnic/racial influences among women underscored the need for assessing the risk factors at both inter-national and intra-national levels to formulate interventions to reduce the burden of PTB. Given this context, the present study was undertaken to elucidate the infectious and non-infectious risk factors for PTB and LBW among Indian pregnant women seeking routine antenatal care at a secondary care hospital.

The PTB rate of 7.6% observed in the present study population is lower as compared to the estimates (15%) reported by the World Health Organization among Indian women \[[@b13-jpmph-49-3-165]\]. Similarly, we observed a lower rate (11.4%) of LBW in our study population as compared to previous reports from other parts of the country \[[@b14-jpmph-49-3-165],[@b15-jpmph-49-3-165]\]. The low rates of PTB and LBW in the present study as compared to the previous reports from other parts of the country could be attributed to the target study population for the following reasons: i) The present study was carried out in Udupi district, which is considered to be one of the more developed districts in the state of Karnataka, India \[[@b16-jpmph-49-3-165]\]. ii) The study population consisted of young women (mean age, 27.18±3.5 years) with higher levels of education. iii) The majority of the study participants belonged to the middle income group (\>10 000 INR/mo), unlike the other studies, which had higher rates of PTB and LBW among women belonging to the low income group and those with lower literacy \[[@b13-jpmph-49-3-165]-[@b15-jpmph-49-3-165]\]. iv) Further, to avoid the confounding effect of other known risk factors for PTB, in the present study we excluded the recruitment of women with a history of smoking, consumption of alcohol, twin and multiple pregnancy, pre-gestational diabetes mellitus, and hypertension.

While PTB is well acknowledged as a multifactorial process, ascending genital tract infections have previously been implicated in at least half of the cases. In particular, the causal relationship between BV and PTB among women from various ethnic groups has been consistently noted. A few studies have reported the magnitude of BV during pregnancy among Indian women (6.4% \[[@b17-jpmph-49-3-165]\], 24.3% \[[@b18-jpmph-49-3-165]\], and 12% \[[@b19-jpmph-49-3-165]\]); however, the paucity of data regarding the potential association of BV with PTB among these women is evident in the published literature. A lower rate of BV (6%) could possibly be attributed to the socioeconomic and lifestyle factors of our study population. BV was reported to be high among women from low socioeconomic strata, and those with low levels of education, a history of smoking, and multiple sex partners \[[@b20-jpmph-49-3-165]-[@b22-jpmph-49-3-165]\], while our study population not fit this description. Further, none of the previously reported studies from India could be matched with our cohort in terms of the sample size and gestational age at the time of testing. With the overall low proportion of women with BV (48/790, 6%) and further loss of six women diagnosed with BV on follow-up, the present study had relatively a small cohort of 42 women with BV for the final outcome analysis. In this context, the finding of BV not being an independent risk factor for PTB and LBW in the present study population is not surprising. Nevertheless, a positive association of BV with PTB as observed using univariate Cox regression in the present study population underscores the need for future studies using a larger sample size to understand the causal relationship in Indian women.

Other forms of vaginal infection like VVC and trichomoniasis were more commonly observed than BV in the present study. However, neither VVC nor trichomoniasis had any statistically significant association with PTB or LBW among the women in this study. These findings are similar to those reported previously among women belonging to other ethnic groups \[[@b23-jpmph-49-3-165],[@b24-jpmph-49-3-165]\]. The causal relationship between intermediate vaginal flora and adverse pregnancy outcomes has been increasingly emphasized in the past two decades \[[@b25-jpmph-49-3-165],[@b26-jpmph-49-3-165]\]. While the exact mechanism by which the presence of these intermediate vaginal flora could lead to PTB is unknown, inflammatory responses primarily due to the abundance of IL1 and IL6 were reported to mediate the production of prostaglandins and cause preterm uterine contractions \[[@b27-jpmph-49-3-165]\]. In the present cohort, women with Nugent's intermediate vaginal flora were found to be at 2.7 times greater risk for preterm delivery than women with normal vaginal flora. To the best of our knowledge, this is the first report suggesting a positive association of intermediate vaginal flora in pregnant Indian women with PTB and PTLBW.

Of the total of 57 (7.1%) women diagnosed with AB and UTI during their first visit, 55 (97%) of them received specific antibiotic therapy, and none of them developed complications like pyelonephritis. Previously from a meta-analysis, it was reported that treatment of AB and UTI among pregnant women was a useful intervention to avoid complications like pyelonephritis and its associated adverse pregnancy outcomes like PTB and LBW \[[@b28-jpmph-49-3-165]\]. From a prospective study among North Indian pregnant women, no association between AB diagnosed early during pregnancy and adverse pregnancy outcomes was reported \[[@b29-jpmph-49-3-165]\]. We attribute the lack of association of AB and UTI with PTB and LBW in the present study to early diagnosis and effective antibiotic treatment. Based on the current study's findings, we recommend the routine screening of pregnant women for the presence of AB during their early pregnancies as a cost-effective intervention to avoid further complications.

The proportion of periodontitis in the present study's population (11.6%) is slightly lower than the overall prevalence (14% to 18%) of the disease reported in the adult population of India \[[@b30-jpmph-49-3-165]\]. This is likely due to our study population comprising women in younger age groups from the middle and upper middle income category, and non-smokers \[[@b31-jpmph-49-3-165],[@b32-jpmph-49-3-165]\]. Previously, a decrease in the incidence of PTB was reported among Indian pregnant women who underwent treatment for periodontitis \[[@b7-jpmph-49-3-165]\]. However, considering the significance of periodontitis as an independent risk factor for both PTB and LBW, as observed in the present study, we emphasize the need for further studies to determine whether early diagnosis and treatment (\<20 weeks of gestation) of these subtle infections can show a reduction in rates of PTB and LBW.

While women with pre-gestational hypertension were excluded from recruitment in the present study, 22 (3%) of the 726 women developed gestational hypertension (after 20 weeks of gestation), which was found to be an independent risk factor for PTB and LBW. A similar association of gestational hypertension was reported among various study populations globally \[[@b1-jpmph-49-3-165],[@b12-jpmph-49-3-165],[@b33-jpmph-49-3-165]\]. Oligohydramnios (amniotic fluid index \<5 cm) during the third trimester of pregnancy was diagnosed in 31 (4.3%) of the women. A similar association of oligohydramnios with adverse pregnancy outcomes as observed in our study was reported previously \[[@b11-jpmph-49-3-165],[@b34-jpmph-49-3-165]\]. A positive association of genital infections (diagnosed based on clinical signs and symptoms alone in the present study) during later stages of pregnancy with LBW suggests the need for future longitudinal studies to assess the implications of changes in the vaginal microbioma during different stages of pregnancy for adverse pregnancy outcomes.

We acknowledge a few limitations of our study. The rate of infections reported in our study represented the proportion of women infected during their early stages of pregnancy only. Considering the homogenous nature of our study population and variation in the rates of these infections due to the socioeconomic and behavioral characteristics of the study population, the rates of infections reported in the present study cannot be generalized to pregnant women with diverse demographic characteristics. The attrition rate of 8% in the study population was also one of our limitations. However, the study findings deduced from women with follow-up data available can be extrapolated to those that were lost to follow-up, as the two groups did not differ significantly in terms of their baseline characteristics and infectious parameters. Screening for the presence of genitourinary and periodontal infections could not be repeated during the later stages of pregnancy in the present study due to resource constraints. If only this could be done, we could have estimated the proportion of women developing new or recurrent infections during the later stages of pregnancy. Despite these limitations, our study findings add significant insight on the role of asymptomatic maternal infections such as intermediate vaginal flora and periodontitis on adverse pregnancy outcomes. These findings have important implications for settings where infection screening is not a routine practice during antenatal care.
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###### 

Comparison of baseline characteristics between study participants with follow-up loss and follow-up completion (n=790)

  Baseline characteristics        Proportion   Follow-up completed (n=726)   Follow-up lost (n=64)   *p*-value
  ------------------------------- ------------ ----------------------------- ----------------------- -----------
  Religion                                                                                           
   Hindu                          694 (87.8)   639 (88.0)                    55 (85.9)               0.27
   Christian                      62 (7.8)     55 (7.5)                      7 (10.9)                
   Muslim                         34 (4.3)     32 (4.4)                      2 (3.1)                 
  Occupation                                                                                         
   Homemaker                      651 (82.4)   603 (83.0)                    48 (75.0)               0.13
   Working                        139 (17.5)   123 (16.9)                    16 (25.0)               
  Monthly income (INR)                                                                               
   \<5000                         41 (5.1)     34 (4.6)                      7 (10.9)                0.60
   5001-10 000                    199 (25.1)   187 (25.7)                    12 (18.7)               
   10 001-15 000                  166 (21.0)   154 (21.2)                    12 (18.7)               
   \>15 000                       384 (48.6)   351 (48.3)                    33 (51.5)               
  Level of education                                                                                 
   \<7 years of schooling         272 (34.4)   245 (33.7)                    27 (42.0)               0.49
   7-12 years of schooling        330 (41.7)   309 (42.5)                    21 (34.0)               
   High school graduate & above   188 (23.7)   172 (23.6)                    16 (24.0)               
  Parity index                                                                                       
   Primigravida                   461 (58.3)   422 (58.1)                    39 (60.9)               0.87
   Second gravida                 261 (33.0)   243 (33.4)                    18 (28.1)               
   Third gravida                  68 (8.6)     61 (8.4)                      7 (11.0)                
  Maternal age (y)                                                                                   
   20-24                          194 (24.5)   177 (24.3)                    17 (26.5)               0.38
   25-29                          395 (50.0)   369 (50.8)                    26 (40.6)               
   30-35                          201 (25.5)   180 (24.7)                    21 (32.8)               
  Maternal height (m)                                                                                
   \<1.50                         146 (18.4)   130 (17.9)                    16 (25.0)               0.12
   ≥1.50                          644 (81.5)   596 (82.0)                    48 (75.0)               
  Maternal BMI at first visit                                                                        
   Normal                         506 (64.0)   471 (64.8)                    35 (54.6)               0.08
   Underweight                    197 (25.0)   178 (24.5)                    19 (29.6)               
   Overweight                     78 (9.8)     70 (9.6)                      8 (12.5)                
   Obese                          9 (1.1)      7 (0.9)                       2 (3.1)                 
  Bacterial vaginosis                                                                                
   Present                        48 (6.0)     42 (5.7)                      6 (9.3)                 0.17
   Absent                         742 (94.0)   684 (94.3)                    58 (90.6)               
  Vulvovaginal candidiasis                                                                           
   Present                        97 (12.2)    86 (11.8)                     11 (17.1)               0.33
   Absent                         693 (87.8)   640 (88.2)                    53 (82.8)               
  Trichomoniasis                                                                                     
   Present                        94 (11.8)    86 (11.8)                     8 (12.5)                1.00
   Absent                         696 (88.2)   640 (88.2)                    56 (87.5)               
  Nugent's grade II flora                                                                            
   Present                        108 (13.6)   101 (13.9)                    7 (10.9)                0.57
   Absent                         682 (86.3)   625 (86.0)                    57 (89.0)               
  Urinary tract infection                                                                            
   Present                        57 (7.2)     50 (6.8)                      7 (10.9)                0.31
   Absent                         733 (92.8)   676 (93.2)                    57 (89.0)               
  Periodontitis                                                                                      
   Present                        90 (11.3)    83 (11.4)                     7 (10.9)                0.22
   Absent                         700 (88.6)   643 (88.5)                    57 (89.0)               

Values are presented as number (%).

INR, Indian rupees; BMI, body mass index.

###### 

Association of maternal physical, demographic, and infectious parameters with PTB, PLBW, and LBW in the study population (n=710)

  Variable                        n (%)        PTB         PTLBW               LBW                                          
  ------------------------------- ------------ ----------- ------------------- ----------- -------------------- ----------- -------------------
  Total                                        54 (7.6)                        34 (4.7)                         47 (6.6)    
  Religion                                                                                                                  
   Hindu                          630 (88.7)   49 (7.8)    1.0 (reference)     30 (4.7)    1.0 (reference)      43 (6.8)    1.0 (reference)
   Christian                      52 (7.3)     5 (9.6)     0.9 (0.26, 3.12)    4 (7.6)     1.9 (0.68, 5.53)     3 (5.7)     1.0 (0.24, 4.75)
   Muslim                         28 (3.9)     0 (0.0)     \-                  0 (0.0)     \-                   1 (3.1)     0.3 (0.04, 2.26)
   *p*-value                                               0.27                            0.38                             0.27
  Occupation                                                                                                                
   Homemaker                      591 (83.3)   46 (7.5)    1.0 (reference)     28 (4.7)    1.0 (reference)      41 (6.9)    1.0 (reference)
   Working                        119 (16.7)   8 (6.7)     0.9 (0.40, 1.90)    6 (5.0)     0.4 (0.15, 1.53)     6 (5.0)     0.5 (0.22, 1.50)
   *p*-value                                               0.66                            0.37                             0.31
  Monthly income (INR)                                                                                                      
   \<5000                         33 (4.6)     2 (6.1)     1.0 (reference)     1 (3.0)     1.0 (reference)      3 (9.0)     1.0 (reference)
   5001-10 000                    181 (25.5)   10 (5.3)    1.1 (0.25, 5.33)    7 (3.8)     0.3 (0.04, 2.83)     16 (8.8)    0.9 (0.26, 3.54)
   10 001-15 000                  145 (20.4)   14 (9.6)    2.2 (0.49, 9.90)    8 (5.5)     0.7 (0.32, 1.90)     11 (7.6)    0.9 (0.24, 3.57)
   \>15 001                       351 (49.4)   28 (8.0)    1.7 (0.41, 7.44)    18 (5.1)    0.7 (0.26, 2.00)     17 (4.9)    0.4 (0.12, 1.73)
   *p*-value                                               0.43                            0.57                             0.18
  Level of education                                                                                                        
   \<7 years of schooling         240 (33.8)   22 (9.1)    1.0 (reference)     15 (6.2)    1.0 (reference)      19 (7.9)    1.0 (reference)
   7-12 years of schooling        301 (42.4)   22 (7.3)    1.6 (0.77, 3.46)    12 (3.9)    1.5 (0.63, 3.83)     18 (5.9)    1.5 (0.71, 3.48)
   High school graduate & above   169 (23.8)   10 (5.9)    1.1 (0.51, 2.37)    7 (4.1)     0.7 (0.29, 2.03)     10 (5.9)    1.2 (0.56, 2.80)
   *p*-value                                               0.17                            0.21                             0.39
  Conception                                                                                                                
   Spontaneous^1^                 695 (97.9)   52 (7.4)    1.0 (reference)     32 (4.6)    1.0 (reference)      46 (6.6)    1.0 (reference)
   Infertility workup             15 (2.1)     2 (13.3)    0.4 (0.10, 1.97)    2 (13.3)    0.2 (0.06, 1.27)     1 (6.6)     1.1 (0.14, 8.77)
   *p*-value                                               0.42                            0.30                             0.61
  Parity index                                                                                                              
   Primigravida                   419 (59.0)   32 (7.6)    1.0 (reference)     18 (4.3)    1.0 (reference)      30 (7.2)    1.0 (reference)
   Second gravida                 232 (32.7)   14 (6.1)    0.5 (0.21, 1.30)    10 (4.3)    0.5 (0.20, 1.66)     14 (6.0)    1.8 (0.43, 8.11)
   Third gravida                  59 (8.3)     8 (14.0)    0.3 (0.12, 0.85)    6 (10.0)    0.3 (0.13, 1.07)     3 (5.1)     1.5 (0.33, 6.98)
   *p*-value                                               0.10                            0.17                             0.33
  Maternal age (y)                                                                                                          
   20-24                          177 (24.9)   19 (10.9)   1.0 (reference)     9 (5.0)     1.0 (reference)      17 (9.6)    1.0 (reference)
   25-29                          354 (49.8)   21 (5.9)    1.5 (0.68, 3.55)    12 (3.3)    0.6 (0.25, 1.67)     20 (5.6)    2.0 (0.87, 4.69)
   30-35                          179 (25.2)   14 (7.8)    0.7 (0.35, 1.67)    13 (7.3)    0.3 (0.15, 0.93)     10 (5.6)    1.0 (0.46, 2.37)
   *p*-value                                               0.24                            0.42                             0.09
  Maternal BMI at first visit                                                                                               
   Normal                         457 (64.3)   31 (6.7)    1.0 (reference)     19 (4.1)    1.0 (reference)      25 (5.4)    1.0 (reference)
   Underweight                    177 (24.9)   14 (7.9)    0.2 (0.04, 1.00)    9 (5.0)     0.2 (0.03, 2.28)     16 (9.0)    0.6 (0.32, 1.18)
   Overweight                     70 (9.8)     7 (10.0)    0.1 (0.04, 0.80)    5 (7.1)     0.2 (0.02, 1.85)     6 (8.5)     1.2 (0.47, 3.11)
   Obese                          6 (0.8)      2 (33.3)    0.3 (0.07, 1.80)    1 (16.6)    0.3 (0.30, 3.17)     0 (0.0)     \-
   *p*-value                                               0.10                            0.26                             0.27
  Previous PTB                                                                                                              
   Yes                            8 (1.1)      3 (37.5)    6.3 (1.96, 20.36)   3 (37.5)    12.9 (2.81, 59.86)   1 (12.5)    3.2 (0.35, 29.52)
   No                             702 (98.9)   51 (7.2)    1.0 (reference)     31 (4.4)    1.0 (reference)      46 (6.5)    1.0 (reference)
   *p*-value                                               0.002                           0.001                            0.31
  Maternal height (m)                                                                                                       
   \<1.50                         126 (17.7)   17 (13.5)   2.0 (1.11, 3.60)    14 (11.1)   2.6 (1.25, 5.32)     17 (13.4)   2.8 (1.40, 5.43)
   ≥1.50                          584 (82.3)   37 (6.3)    1.0 (reference)     20 (3.4)    1.0 (reference)      30 (5.1)    1.0 (reference)
   *p*-value                                               0.02                            0.01                             0.003
  Bacterial vaginosis                                                                                                       
   Present                        42 (5.9)     7 (16.7)    3.2 (1.02, 10.41)   6 (14.2)    1.8 (0.60, 5.37)     5 (11.9)    1.4 (0.53, 4.16)
   Absent                         668 (94.1)   47 (7.0)    1.0 (reference)     28 (4.1)    1.0 (reference)      42 (6.2)    1.0 (reference)
   *p*-value                                               0.05                            0.06                             0.17
  VVC                                                                                                                       
   Present                        84 (11.8)    7 (8.3)     0.8 (0.34, 2.08)    4 (4.7)     0.7 (0.24, 2.27)     6 (7.1)     0.8 (0.34, 2.16)
   Absent                         626 (88.2)   47 (7.5)    1.0 (reference)     30 (4.7)    1.0 (reference)      41 (6.5)    1.0 (reference)
   *p*-value                                               0.71                            0.92                             0.81
  Trichomoniasis                                                                                                            
   Present                        84 (11.8)    5 (5.9)     0.3 (0.08, 1.57)    3 (3.5)     0.9 (0.28, 3.22)     3 (3.5)     0.3 (0.08, 1.56)
   Absent                         626 (88.2)   49 (7.8)    1.0 (reference)     31 (4.9)    1.0 (reference)      44 (7.0)    1.0 (reference)
   *p*-value                                               0.18                            0.41                             0.35
  Nugent's grade II flora                                                                                                   
   Present                        78 (11.0)    13 (16.6)   1.1 (0.45, 2.81)    11 (14.0)   0.4 (0.17, 1.10)     7 (8.9)     0.9 (0.40, 2.44)
   Absent                         632 (89.0)   41 (6.5)    1.0 (reference)     23 (3.6)    1.0 (reference)      40 (6.3)    1.0 (reference)
   *p*-value                                               0.78                            0.006                            0.66
  Urinary tract infection                                                                                                   
   Present                        48 (6.8)     3 (6.2)     1.2 (0.39, 4.18)    3 (6.2)     1.5 (0.47, 5.30)     3 (6.2)     0.8 (0.38, 4.16)
   Absent                         662 (93.2)   51 (7.7)    1.0 (reference)     31 (4.6)    1.0 (reference)      44 (6.6)    1.0 (reference)
   *p*-value                                               0.68                            0.69                             0.87
  Periodontitis                                                                                                             
   Present                        81 (11.4)    11 (13.5)   3.4 (1.73, 6.93)    8 (9.8)     2.8 (1.26, 6.49)     12 (14.8)   3.4 (1.71, 6.80)
   Absent                         629 (88.6)   43 (6.8)    1.0 (reference)     24 (3.8)    1.0 (reference)      35 (5.5)    1.0 (reference)
   *p*-value                                               \<0.001                         0.001                            0.003
  Gestational hypertension                                                                                                  
   Present                        22 (3.0)     6 (11.1)    3.3 (1.15, 9.56)    3 (13.6)    3.5 (1.52, 8.44)     4 (18.1)    3.0 (1.28, 7.07)
   Absent                         688 (97.0)   49 (7.1)    1.0 (reference)     31 (4.5)    1.0 (reference)      43 (6.2)    1.0 (reference)
   *p*-value                                               0.02                            0.001                            0.02
  Oligohydramnios                                                                                                           
   Present                        31 (4.3)     8 (25.8)    4.8 (2.24, 10.63)   7 (22.5)    2.7 (1.07, 6.93)     4 (12.9)    5.6 (2.91, 10.84)
   Absent                         679 (95.6)   46 (6.7)    1.0 (reference)     27 (3.9)    1.0 (reference)      43 (6.3)    1.0 (reference)
   *p*-value                                               \<0.001                         \<0.001                          0.05
  Gestational diabetes mellitus                                                                                             
   Present                        38 (5.3)     4 (10.5)    1.9 (0.67, 5.59)    3 (7.9)     1.2 (0.37, 3.93)     2 (5.2)     1.7 (0.69, 4.42)
   Absent                         672 (94.6)   50 (7.4)    1.0 (reference)     31 (4.6)    1.0 (reference)      45 (6.6)    1.0 (reference)
   *p*-value                                               0.34                            0.47                             1.00
  UTI during follow-up                                                                                                      
   Present                        23 (3.1)     3 (13.0)    1.2 (0.38, 4.25)    1 (4.3)     0.6 (0.15, 2.75)     0 (0.0)     0.2 (0.30, 1.76)
   Absent                         687 (96.9)   51 (7.4)    1.0 (reference)     33 (4.8)    1.0 (reference)      47 (6.8)    1.0 (reference)
   *p*-value                                               0.41                            0.87                             0.39
  GI during follow-up                                                                                                       
   Present                        65 (9.1)     6 (9.2)     1.3 (0.55, 3.13)    2 (3.0)     0.7 (0.17, 3.13)     9 (13.8)    2.0 (1.05, 3.81)
   Absent                         645 (90.8)   48 (7.4)    1.0 (reference)     32 (4.9)    1.0 (reference)      38 (5.8)    1.0 (reference)
   *p*-value                                               0.45                            0.13                             0.01

The CRR was determined using Cox regression analysis.

PTB, preterm birth; PTLBW, preterm low birth weight; LBW, low birth weight; CRR, crude relative risk; CI, confidence interval; INR, Indian rupees; BMI, body mass index; VVC, vulvovaginal candidiasis; UTI, urinary tract infection; GI, genital infection.

###### 

Independent risk factors for PTB, PTLBW, and LBW in the study population

  Risk factors                                         PTB                PTLBW             LBW
  ---------------------------------------------------- ------------------ ----------------- ------------------
  Previous preterm delivery                            5.37 (1.5, 19.1)   \-                \-
   *p*-value                                           0.009                                
  Periodontitis                                        2.39 (1.1, 4.9)    3.29 (1.8, 5.7)   3.38 (1.6, 6.9)
   *p*-value                                           0.02               \<0.001           0.001
  Oligohydramnios                                      5.23 (2.4, 11.5)   4.67 (2.3, 9.3)   \-
   *p*-value                                           \<0.001            \<0.001           
  Nugent's intermediate vaginal flora                  2.75 (1.4, 5.1)    2.19 (1.3, 3.7)   \-
   *p*-value                                           0.002              0.005             
  Gestational diabetes mellitus                        2.91 (1.0, 8.3)    \-                \-
   *p*-value                                           0.05                                 
  Maternal height (\<1.50 m)                           2.21 (1.1, 4.1)    3.10 (1.8, 5.1)   2.66 (1.3, 5.1)
   *p*-value                                           0.01               \<0.001           0.004
  Gestational hypertension                             \-                 2.90 (1.1, 7.3)   3.70 (1.3, 10.8)
   *p*-value                                                              0.02              0.01
  Genital infection during later stages of pregnancy   \-                 \-                2.79 (1.2, 6.1)
   *p*-value                                                                                0.01

Value are presented as adjusted relative risk (95% confidence interval). The relative risk was calculated using the Cox proportional hazard model and estimated after adjusting for age, level of education, parity, monthly household income, and maternal body mass index in the study population.

PTB, preterm birth; PTLBW, preterm low birth weight; LBW, low birth weight.
